Archamps (France) and Geneva (Switzerland), June 28th, 2017 at 6:00pm CEST. Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today ...
Archamps (France) and Geneva (switzerland), June 27th, 2017 at 6:00 pm CEST Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX.pa), a biopharmaceutical company and the leader in NOX therapies, announced to ...
Geneva, Switzerland, 19 June 2017 - 7:30am CEST : - GeNeuro (Euronext Paris : CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for autoimmune diseases, announced today that the first patient ha ...
Geneva (Switzerland), 12 june 2017 - 7:30am CEST : - GeNeuro (Euronext Paris : CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, announced tod ...
Toulouse and Geneva, May 2nd, 2017 Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today that the U.S. Food & Drug Administra ...
Geneva (Switzerland), April 18, 2017 : GeNeuro (Euronext Paris : CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, announced today the initiat ...
